CFO
Matthias Bodenstedt is the Chief Financial Officer (CFO) of MoonLake Immunotherapeutics (MLTX), a clinical-stage biopharmaceutical company focused on immunology therapies, including sonelokimab.[[1]](https://www.marketscreener.com/insider/MATTHIAS-BODENSTEDT-A3CGK3/)[[2]](https://www.prnewswire.com/news-releases/moonlake-immunotherapeutics-appoints-jorge-santos-da-silva-as-ceo-and-matthias-bodenstedt-as-cfo-301322284.html)[[6]](https://moonlaketx.com/about-us/) He joined the company in this role starting September 1, 2021, with MoonLake Immunotherapeutics AG, and has held the position since April 4, 2022, while also serving as Director since August 31, 2021, and Director at related entities like Moonlake Immunotherapeutics Ltd. and MNLK Immunotherapeutics Unipessoal Lda.[[1]](https://www.marketscreener.com/insider/MATTHIAS-BODENSTEDT-A3CGK3/)[[4]](https://contracts.justia.com/companies/helix-acquisition-corp-11268/contract/227907/)
Prior to MoonLake, Bodenstedt was a Partner at McKinsey & Company from 2015 to 2021, where he advised biopharmaceutical clients on finance, M&A, business development, portfolio strategy, and go-to-market execution, spanning pre-revenue biotechs to global pharma firms.[[1]](https://www.marketscreener.com/insider/MATTHIAS-BODENSTEDT-A3CGK3/)[[2]](https://www.prnewswire.com/news-releases/moonlake-immunotherapeutics-appoints-jorge-santos-da-silva-as-ceo-and-matthias-bodenstedt-as-cfo-301322284.html) His education includes an MBA from Columbia Business School, an MPhil in Finance from the University of Cambridge, and a BSc in Industrial Engineering from the University of Hannover.[[1]](https://www.marketscreener.com/insider/MATTHIAS-BODENSTEDT-A3CGK3/)[[2]](https://www.prnewswire.com/news-releases/moonlake-immunotherapeutics-appoints-jorge-santos-da-silva-as-ceo-and-matthias-bodenstedt-as-cfo-301322284.html) As a corporate insider, he sold 100,000 MLTX shares on December 20, 2023, and holds approximately 520,903 shares valued at over $23 million as of mid-2025, with 2023 compensation totaling $891,597.[[3]](https://www.gurufocus.com/insider/180330/matthias-bodenstedt)
View full insider profile →
